Gagnon Advisors’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Gagnon Advisors’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-556,755	Closed	-$729K	–	29
2023 Q3	$729K	Hold	556,755	–	–	0.61%	25
2023 Q2	$974K	Hold	556,755	–	–	0.65%	26
2023 Q1	$935K	Buy	556,755 +326,953	+142%	+$850K	0.63%	26
2022 Q4	$687K	Sell	229,802 -149,618	-39%	-$587K	0.46%	26
2022 Q3	$1.66M	Sell	379,420 -80,184	-17%	-$259K	1.08%	27
2022 Q2	$1.83M	Hold	459,604	–	–	1.11%	27
2022 Q1	$1.82M	Buy	459,604 +229,802	+100%	+$856K	0.84%	29
2021 Q4	$1.08M	Hold	229,802	–	–	0.43%	30
2021 Q3	$1.6M	Hold	229,802	–	–	0.63%	31
2021 Q2	$2.68M	Buy	+229,802	New	+$2.96M	1.02%	28

Gagnon Advisors's MIRO Position: Q4 2023 in Review

Gagnon Advisors sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 556,755 shares — an estimated $729K sold.

Gagnon Advisors first reported a position in MIRO in Q2 2021 and held it in 10 quarters. The position peaked at $2.68M in Q2 2021. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

Gagnon Advisors reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Gagnon Advisors sold 556,755 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $729K.
Gagnon Advisors first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Gagnon Advisors's Miromatrix Medical Inc. Common Stock position peaked at $2.68M in Q2 2021.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Gagnon Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.